Nested randomized trials in large cohorts and biobanks: Studying the health effects of lifestyle factors

Epidemiology

Volumn 19, Issue 1, 2008, Pages 75-82

  Ioannidis, John P A ^a,b,e   Adami, Hans Olov ^c,d  

^a INSTITUTE OF COMPUTER SCIENCE   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BLOOD PRESSURE MEASUREMENT; COLORECTAL CANCER; DIABETES MELLITUS; DIETARY INTAKE; FACTORIAL ANALYSIS; FOLLOW UP; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH STATUS; HEREDITY; HUMAN; LABORATORY DIAGNOSIS; LIFESTYLE; PRIORITY JOURNAL; REGISTER;

CASE-CONTROL STUDIES; COHORT STUDIES; EPIDEMIOLOGIC FACTORS; EPIDEMIOLOGIC RESEARCH DESIGN; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; POPULATION SURVEILLANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 37349111038     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31815be01c     Document Type: Article

References (54)

1. Stampfer M. Observational epidemiology is the preferred means of evaluating effects of behavioral and lifestyle modification. Control Clin Trials. 1997;18:494-499; discussion 514-516.
2. Prentice RL, Pettinger M, Anderson GL. Statistical issues arising in the Women's Health Initiative. Biometrics. 2005;61:899-911; discussion 911-941.
3. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
4. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:655-666.
5. Dansinger ML, Gleason JA, Griffith JL, et al. Comparison of the atkins, ornish, weight watchers, and zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293:43-53.
6. Province MA, Hadley EC, Hornbrook MC, et al. The effects of exercise on falls in elderly patients. A preplanned meta-analysis of the FICSIT Trials. Frailty and injuries: cooperative studies of intervention techniques. JAMA. 1995;273:1341-1347.
7. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349:215-224.
8. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005;97:94-102.
9. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-160.
10. Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005;294:218-228.
11. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005;2:e124.
12. von Elm E, Egger M. The scandal of poor epidemiological research. BMJ. 2004;329:868-869.
13. Skrabanek P. Has risk-factor epidemiology outlived its usefulness? Am J Epidemiol. 1993;138:1016-1017.
14. Taubes G. Epidemiology faces its limits. Science. 1995;269:164-169.
15. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005;6:95-108.
16. Palmer LJ, Cardon LR. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet. 2005;366:1223-1234.
17. Collins FS. The case for a US prospective cohort study of genes and environment. Nature. 2004;429:475-477.
18. Collins FS, Manolio TA. Merging and emerging cohorts: necessary but not sufficient. Nature. 2007;445:259.
19. Ioannidis JP, Gwinn M, Little J, et al. A road map for efficient and reliable human genome epidemiology. Nat Genet. 2006;38:3-5.
20. Davey Smith G, Ebrahim S. Mendelian randomization: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1-22.
21. Ioannidis JP, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet. 2001;29:306-309.
22. Ioannidis JP. Genetic associations: false or true? Trends Mol Med. 2003;9:135-138.
23. Pocock SJ, Collier TJ, Dandreo KJ, et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ. 2004;329:883.
24. Botto LD, Khoury MJ. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol. 2001;153:1016-1020.
25. Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality. Pharmacogenomics. 2005;6:639-646.
26. Public Population Project in Genomics. Accessed at: http://www. p3gconsortium.org.
27. Tavani A, La Vecchia C. Coffee and cancer: a review of epidemiological studies, 1990-1999. Eur J Cancer Prev. 2000;9:241-256.
28. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA. 2005;294:97-104.
29. Sala M, Cordier S, Chang-Claude J, et al. Coffee consumption and bladder cancer in nonsmokers: a pooled analysis of case-control studies in European countries. Cancer Causes Control. 2000;11:925-931.
30. Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev. 2004;13:340-345.
31. Adami HO. A paradise for epidemiologists? Lancet. 1996;347:588-589.
32. Haidich AB, Ioannidis JP. Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. Am J Epidemiol. 2001;154:873-880.
33. Wendler D. Can we ensure that all research subjects give valid consent? Arch Intern Med. 2004;164:2201-2204.
34. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA. 2004;292:1593-1601.
35. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720-2726.
36. Michels KB. The women's health initiative - curse or blessing? Int J Epidemiol. 2006;35:814-816.
37. Kriska AM, Bayles C, Cauley JA, et al. A randomized exercise trial in older women: increased activity over two years and the factors associated with compliance. Med Sci Sports Exerc. 1986;18:557-562.
38. Irwin ML, Tworoger SS, Yasui Y, et al. Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. Prev Med. 2004;39:1080-1086.
39. Courneya KS, Segal RJ, Reid RD, et al. Three independent factors predicted adherence in a randomized controlled trial of resistance exercise training among prostate cancer survivors. J Clin Epidemiol. 2004;57:571-579.
40. Women's Health Initiative Study Group.Dietary adherence in the Women's Health Initiative Dietary Modification Trial. J Am Diet Assoc 2004;104:654-658.
41. Shapiro S. Looking to the 21st century: have we learned from our mistakes, or are we doomed to compound them? Pharmacoepidemiol Drug Saf. 2004;13:257-265.
42. Robins JM. A new approach to causal inference in mortality studies with sustained exposure periods-application to control of the healthy worker survivor effect. Math Model. 1986;7:1393-1512.
43. Robins JM. Addendum to "A new approach to causal inference in mortality studies with sustained exposure periods-application to control of the healthy worker survivor effect". Comput Math Appl. 1987;14:923-945.
44. Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366:378-384.
45. Hernan MA. A definition of causal effect for epidemiological research. J Epidemiol Community Health. 2004;58:265-271.
46. Ioannidis JPA. Evolution and translation of research findings: from bench to where? PLoS Clin Trials. 2006;1:e36.
47. Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348:2599-2608.
48. Piantadosi S. Clinical Trials: A Methodological Approach. Wiley; 1997.
49. DeMets DL, Lan KK. Interim analysis: the alpha spending function approach. Stat Med. 1994;13:1341-1352; discussion 1353-1356.
50. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
51. Balk EM, Bonis PA, Moskowitz H, et al. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA. 2002;287:2973-2982.
52. Bent S, Kene C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006;354:557-566.
53. Ness AR, Maynard M, Frankel S, et al. Diet in childhood and adult cardiovascular and all cause mortality: the Boyd Orr cohort. Heart. 2005;91:894-898.
54. Frankel S, Gunnell DJ, Peters TJ, et al. Childhood energy intake and adult mortality from cancer: the Boyd Orr Cohort Study. BMJ. 1998;316:499-504.